Massive-Bio

Massive Bio and Optellum Partner to Expand Clinical Trial Access for Early-Stage NSCLC Patients

Massive Bio and Optellum Partner to Expand Early-Stage Lung Cancer Clinical Trial Access Through AI Massive Bio and Optellum have announced a strategic collaboration aimed at transforming the way patients with early-stage non-small cell lung cancer (NSCLC) are identified and…

Read MoreMassive Bio and Optellum Partner to Expand Clinical Trial Access for Early-Stage NSCLC Patients

Nephrodite’s Holly Implantable Dialysis System Selected for FDA TAP Program

Nephrodite’s Holly Implantable Dialysis System Selected for FDA TAP Program, Advancing Path Toward Clinical Development Nephrodite, a medical technology company focused on transforming treatment options for patients with end-stage kidney disease, has announced that its Holly™ implantable continuous dialysis system…

Read MoreNephrodite’s Holly Implantable Dialysis System Selected for FDA TAP Program
eternalHealth

eternalHealth, Zynix AI and nirvanaHealth Partner on AI Care Management

eternalHealth, Zynix AI, and nirvanaHealth Partner to Advance AI-Powered Care Management and Member Engagement EternalHealth, a Medicare Advantage organization serving beneficiaries across Massachusetts and Arizona, has announced a strategic partnership with healthcare technology companies Zynix AI and nirvanaHealth to strengthen…

Read MoreeternalHealth, Zynix AI and nirvanaHealth Partner on AI Care Management